Document is current
Any future updates will be listed below
-
Authors
Lapi, Francesco https://orcid.org/0000-0002-4342-9128
Marconi, Ettore
Medea, Gerardo
Cricelli, Iacopo
Parretti, Damiano
Rossi, Alessandro
Cricelli, Claudio
-
Funding
Funding for this research was provided by:
Roche Diagnostics. Italy
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 31 December 2024
First Online: 12 January 2025
Compliance with ethical standards
:
: F.L., E.M., and I.C. provided consultancies in protocol preparation for epidemiological studies and data analyses for Roche Diagnostics, Astra Zeneca, Novartis, MSD. IC is an employee at Genomedics SRL. G.M., D.P., A.R. and C.C. provided clinical consultancies for Roche Diagnostics, Astra Zeneca, Novartis, MSD.
: The study protocol was approved by the Scientific Committee of the Italian College of General Practitioners and Primary Care. This study followed the principles of the Declaration of Helsinki, and it is compliant with the ENCePP (European Network of Centres for Pharmacoepidemiology and Pharmacovigilance) Guide on Methodological Standards in Pharmacoepidemiology. Furthermore, as this is a retrospective, non‐interventional, non-pharmacological observational study. There is therefore no need for informed consent (Italian Drug Agency note dated 3rd of August 2007; GU n.31 7th February 2023).
: Not applicable.
: Not applicable.
